<DOC>
	<DOC>NCT00762242</DOC>
	<brief_summary>The purpose of this study is to identify and characterize specific chemicals and metabolic pathways that change with forearm ischemia. These changes will be compared with forearm blood flow and flow-mediated vasodilation of the brachial artery.</brief_summary>
	<brief_title>Metabolomic Profiling of Novel Mediators of Vascular Function</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Adults age 18 or older Type 2 diabetes mellitus Type 1 diabetes mellitus Type 2 diabetics taking insulin, thiazolidinediones (rosiglitazone or pioglitazone), an amylin analog (Symlin [pramlintide]), or incretin mimetics (Byetta [exenatide]) Pregnancy Uncontrolled hypertension, &gt; 180/100 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>metabolomics</keyword>
	<keyword>flow-mediated vasodilation</keyword>
</DOC>